This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Glucose transporter type I deficiency syndrome (GLUT1 DS OMIM No. 606777) is an inborn error of glucose transport characterized by seizures, developmental delay, spasticity, acquired microcephaly, and ataxia.1 In addition, in many patients paroxysmal events other than epilepsy have been described,2 but limited information is available regarding their phenomenology and classification. We report on clinical and genetic features of three unrelated Italian female patients with GLUT1 DS, diagnosed in early adulthood, all presenting with paroxysms of abnormal movements as the most relevant and disabling symptom.
Methods.
Medical history was obtained from interviews of patients and their relatives and from medical records. Patients were diagnosed with GLUT1 DS according to the established clinical and biochemical criteria and confirmed by genetic testing.1 Patients and healthy relatives’ DNA was extracted from venous peripheral blood lymphocytes according to standard procedures. All exons and intron-exons boundaries (exon 1–10) of the GLUT1 gene were tested for mutations by direct sequence analysis using an automated sequencing system (ABI Prism 3100 Genetic Analyzer; Applied Biosystems). Real time PCR was performed (7300 Real-Time PCR System, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker